Last updated: 2026/04/14
- Home
- Small Molecule
- Crystal Bio Solutions
- Crystal NAX
- Platforms
- Resources
- Highlights
- News
- Crystal Pharmatech | Reflecting on 2025
- Patients can’t carry a fridge around: research meets the real world
- Crystal Pharmatech Launches OEB4/OEB5 High-Potency Laboratory, Expanding Global CDMO Capabilities for Complex Drug Development
- Improving the Manufacture of mRNA Biologics
- Technical Guideline for the Study of Polymorphism of Innovative Chemical Drugs by National Medical Products Administration (NMPA)
- CATUG and Crystal Bio Establish Strategic Partnership, Launching “CATUG-Crystal” Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services
- Dr. LianFeng Huang Joins Crystal Pharmatech as Chief Scientist
- Crystal Formulation Services successfully passed the dual certification of GMP and GDP conducted by SGS
- Industry Shift: FDA Goes Vegan?
- Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
- Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services
- Crystal Pharmatech Returned to AAPS 2022 PharmSci 360
- Crystal Pharmatech and Particle Sciences Form a US-China Pharmaceutical CRO Partnership
- Crystal Pharmatech Raises $10 Million to Accelerate Growth
- Crystal Formulation Services, Formulation Tailor-made for Your Molecules
- Candoo Enables the Successful Development of a BCS 4 Combo Drug Product
- International Company Crystal Pharmatech Finds CCIT An Optimal Spot for First US Location
- Crystal Pharmatech Triples Headquarters in Biobay, China, with More Floors and Labs
- Xceleron and Crystal Pharmatech Announce Partnership to Improve Early Clinical Development Utilizing Absolute Bioavailability Trials and Solid-State Solutions
- Crystal Pharmatech Introduces Customized Service Packages for Customers Seeking Materials Science Approaches in Drug Discovery and Development
- Crystal Pharmatech Expands Leadership Team
- Crystal Formulation Services（CFS）Opens New Formulation Development Center and Analytical R&D Lab in Suzhou, China
- Candoo's Formulation Technology Platform Featured in the Drug Development & Delivery Journal
- Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
- Crystal Bio Welcomes Dr. Shiaw-Lin (Billy) Wu as Co-Founder and Chief Scientific Officer
- Crystal Bio Appoints Dr. Ye Gu as Co-founder, CTO, and Head of USA BD
- Crystal Pharmatech's CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit
- Crystal Pharmatech and Divamics Announce Strategic Collaboration to Accelerate Drug Development through AI, Crystal Form, and Formulation Innovation
- Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
- Brise Pharma Presents“Best Partner”Trophy to Crystal Formulation Services, Recognizing Their Excellence in Drug Product CDMO Services
- Events
- Knowledge Hub
- Webinar Series
- About Us
- Careers
- Contact Us
Homepage